CIK: 0000314957 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Oct 16, 2024
Total Value ($000): $118,277 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BND | VANGUARD BD INDEX FDS TOTAL BND MRKT | 552,830 | $41,523 | 35.1% | $77.46 | — | TOTAL BND MRKT | 921937835 |
| VT | VANGUARD INTL EQUITY INDEX F | 335,471 | $40,156 | 34.0% | $107.84 | — | TT WRLD ST ETF | 922042742 |
| VOO | VANGUARD INDEX FDS | 68,413 | $36,212 | 30.6% | $463.02 | — | S&P 500 ETF SHS | 922908363 |
| NKGN | NKGEN BIOTECH INC | 550,000 | $208 | 0.2% | $3.23 | -72.5% | COM | 65488A101 |
| PYXS | PYXIS ONCOLOGY INC | 48,731 | $179 | 0.2% | $1.50 | +133.2% | COMMON STOCK | 747324101 |